Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago

Save on this medicine

Other brands with the same active ingredient

These brands contain the same active ingredient (Budesonide + Formoterol Fumarate). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.

Indications & Uses

Budemet 400 Convicap is indicated for:

Dosage Reference

Reference Information Only

Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.

Adults:

Dosage Inhaler (For Asthma): For adults and adolescents aged 12 years and older, the recommended maintenance dose is 1 puff twice daily or 2 puffs once daily. For some patients a maintenance dose of 2 puffs twice daily may be appropriate (for the 160/4.5 mcg/inhalation strength only). Patients should take 1 additional puff as needed in response to symptoms, and if symptoms persist after a few minutes, the additional puff should be taken. Not more than 6 puffs should be taken on any single occasion. For children, the usual maintenance dose is 1 to 2 puffs once or twice daily. Patients should take 1 additional puff as needed in response to symptoms, and if symptoms persist after a few minutes, the additional puff should be taken. Not more than 4 puffs should be taken on any single occasion. Inhalation Capsule (For Asthma): There are two alternative dosage regimens for the treatment of asthma with Budesonide and Formoterol combination, using the Budesonide and Formoterol 100 and 200 Inhalation Capsule for maintenance and reliever therapy. For adults and adolescents aged 12 years and older, the maintenance dose is one Budesonide and Formoterol 100 or 200 Inhalation Capsule twice daily, with a reliever dose of 1 additional Inhalation Capsule as needed in response to symptoms. If symptoms persist after a few minutes, an additional Inhalation Capsule should be taken. Not more than 6 Inhalation Capsules should be taken on any single occasion. A total daily dose of more than 8 Inhalation Capsules is not normally needed, although a total daily dose of up to 12 Inhalation Capsules can be used temporarily. For children aged 4 years and older, the maintenance dose is one Budesonide and Formoterol 100 Inhalation Capsule once daily, with a reliever dose of 1 additional Inhalation Capsule as needed in response to symptoms. If symptoms persist after a few minutes, an additional Inhalation Capsule should be taken. Not more than 4 Inhalation Capsules should be taken on any single occasion. A total daily dose of more than 4 Inhalation Capsules is not normally needed, although a total daily dose of up to 8 Inhalation Capsules could be used temporarily. Inhalation Capsule (For COPD): For adults aged 40 years and older, the dose is 2 Inhalation Capsules of the 200 strength twice daily, up to a maximum daily maintenance dose of 4 Inhalation Capsules, or 1 Inhalation Capsule of the 400 strength twice daily, up to a maximum daily maintenance dose of 2 Inhalation Capsules.

Side Effects

As the combination inhaler contains Formoterol Fumarate and Budesonide, the type and severity of adverse reactions associated with each of the compounds may be expected. There is no incidence of additional adverse events following concurrent administration of the two compounds. Adverse events, which have been associated with Formoterol Fumarate Dihydrate and Budesonide, are given below:Formoterol Fumarate: Tremor, palpitations and headache are common adverse events. Cardiac arrhythmias, muscle cramps and hypersensitivity reactions, including rash, oedema and angiooedema are uncommon and rare.Budesonide: Hoarseness, candida infection in the oropharynx and throat irritation may occur in some patients. Cutaneous hypersensitivity reactions, respiratory tract infections, immunosuppression, growth effect in children, glaucoma & cataract have been reported.

Cautions & Contraindications

Warnings & Precautions

Caution is advised when using this medicine in patients with diabetes mellitus, thyrotoxicosis, untreated low blood potassium (hypokalaemia), severe high blood pressure, and serious heart conditions such as ischaemic heart disease, a fast heart rate (tachycardia) or severe heart failure, as well as in those with glaucoma, cataract, or hypercorticism. In rare cases, the medicine can trigger paradoxical bronchospasm, where wheezing and breathlessness suddenly worsen right after a dose instead of improving. Should this happen, the medication should be stopped immediately.

Contraindications

This is contraindicated in the following conditions: as the primary treatment for status asthmaticus or other acute episodes of asthma or COPD where intensive measures are required, and in anyone with hypersensitivity to any of the ingredients in this preparation.

Drug Interactions

Open checker →
Major Ritonavir
Last updated: 15 Aug 2026